1. Home
  2. COEP vs SWIN Comparison

COEP vs SWIN Comparison

Compare COEP & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • SWIN
  • Stock Information
  • Founded
  • COEP 2017
  • SWIN 2017
  • Country
  • COEP United States
  • SWIN Hong Kong
  • Employees
  • COEP N/A
  • SWIN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • SWIN
  • Sector
  • COEP Health Care
  • SWIN
  • Exchange
  • COEP Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • COEP 27.4M
  • SWIN 214.1M
  • IPO Year
  • COEP N/A
  • SWIN 2023
  • Fundamental
  • Price
  • COEP $10.99
  • SWIN $3.94
  • Analyst Decision
  • COEP
  • SWIN
  • Analyst Count
  • COEP 0
  • SWIN 0
  • Target Price
  • COEP N/A
  • SWIN N/A
  • AVG Volume (30 Days)
  • COEP 56.9K
  • SWIN 216.6K
  • Earning Date
  • COEP 08-15-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • COEP N/A
  • SWIN N/A
  • EPS Growth
  • COEP N/A
  • SWIN N/A
  • EPS
  • COEP N/A
  • SWIN N/A
  • Revenue
  • COEP $62,874.00
  • SWIN $3,316,000.00
  • Revenue This Year
  • COEP N/A
  • SWIN $29.79
  • Revenue Next Year
  • COEP N/A
  • SWIN $54.60
  • P/E Ratio
  • COEP N/A
  • SWIN N/A
  • Revenue Growth
  • COEP N/A
  • SWIN N/A
  • 52 Week Low
  • COEP $2.31
  • SWIN $1.16
  • 52 Week High
  • COEP $13.70
  • SWIN $4.40
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.53
  • SWIN 59.60
  • Support Level
  • COEP $11.30
  • SWIN $3.29
  • Resistance Level
  • COEP $12.71
  • SWIN $3.99
  • Average True Range (ATR)
  • COEP 0.89
  • SWIN 0.39
  • MACD
  • COEP 0.18
  • SWIN -0.04
  • Stochastic Oscillator
  • COEP 54.39
  • SWIN 80.93

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: